From: Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481]
Outcome measures
Projected 5-year risk (%, from the UKPDS risk engine)
<5%
5%–<10%
10%–<15%
15%–<20%
≥20%
All CHD
24.6
37.0
20.7
9.5
8.2
Fatal CHD
56.1
26.8
9.9
4.6
2.6
All stroke
79.3
17.0
2.8
0.7
0.2
Fatal stroke
99.9
0.1
0.0